Access to antiviral therapy for chronic hepatitis B during COVID-19

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorBERTOLLI, Marilia Rocha
dc.contributor.authorROCHA, Priscilla Alves
dc.contributor.authorPINTO, Vanusa Barbosa
dc.contributor.authorONO, Suzane Kioko
dc.date.accessioned2023-09-01T13:46:11Z
dc.date.available2023-09-01T13:46:11Z
dc.date.issued2022
dc.description.abstractAbstract OBJECTIVE: Hepatitis B is an important public health concern. Currently, the COVID-19 pandemic is a major challenge for health systems, and the access to pharmacologic and non-pharmacologic treatment of chronic diseases, such as hepatitis B, may have been affected due to the contingency measures. This study aimed to evaluate the access to antiviral therapy during the ongoing pandemic. METHODS: This was a descriptive analysis of the access to treatment for chronic hepatitis B at a tertiary-level university hospital in São Paulo, integrated with the Brazilian health system. The study was conducted from April to December 2020. RESULTS: Access to antiviral therapy for 225 patients was assessed. The majority of the population was male (59%). The main type of service was the Programa Medicamento em Casa (Home Medication Delivery Program), which was availed by 144 (64%) patients. Women had poorer access to antiviral therapy (56%, p<0.05), and patients registered in the HMDP (68%, p<0.05) had better access. The age group of >48 years represented 70% of the group without access to antiviral therapy. Twenty-two pharmaceutical appointments were conducted through phone calls with patients without access to antiviral therapy. CONCLUSION: This study contributes to the rationalization of efforts in a public health crisis through the identification of groups with the highest risk of poor access to antiviral therapy and the demonstration of the benefits of a medication delivery system.eng
dc.description.indexMEDLINE
dc.description.indexPubMed
dc.description.indexSciELO
dc.description.indexScopus
dc.identifier.citationREVISTA DA ASSOCIAçãO MéDICA BRASILEIRA, v.68, n.11, p.1509-1513, 2022
dc.identifier.doi10.1590/1806-9282.20210300
dc.identifier.issn1806-9282
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/55826
dc.language.isoengpor
dc.publisherAssociação Médica Brasileiraeng
dc.relation.ispartofRevista da Associação Médica Brasileira
dc.rightsopenAccesseng
dc.rights.holderCopyright Associação Médica Brasileiraeng
dc.subjectHepatitis Beng
dc.subjectAntiviral agentseng
dc.subjectCOVID-19eng
dc.subjectPublic healtheng
dc.subject.wosMedicine, General & Internaleng
dc.titleAccess to antiviral therapy for chronic hepatitis B during COVID-19eng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.citation.scopus1
hcfmusp.contributor.author-fmusphcMARILIA ROCHA BERTOLLI
hcfmusp.contributor.author-fmusphcPRISCILLA ALVES ROCHA
hcfmusp.contributor.author-fmusphcVANUSA BARBOSA PINTO
hcfmusp.contributor.author-fmusphcSUZANE KIOKO ONO
hcfmusp.description.beginpage1509
hcfmusp.description.endpage1513
hcfmusp.description.issue11
hcfmusp.description.volume68
hcfmusp.origemsciELO
hcfmusp.origem.pubmed36449766
hcfmusp.origem.scieloSCIELO:S0104-42302022001101509
hcfmusp.origem.scopus2-s2.0-85143095627
hcfmusp.relation.referenceAbreu RM, 2019, ANTIVIR THER, V24, P567, DOI 10.3851/IMP3338eng
hcfmusp.relation.referenceAbreu RM, 2016, INFECT DIS THER, V5, P53, DOI 10.1007/s40121-015-0101-yeng
hcfmusp.relation.referenceAghemo A, 2020, DIGEST LIVER DIS, V52, P937, DOI 10.1016/j.dld.2020.07.008eng
hcfmusp.relation.reference[Anonymous], 2020, LANCET GASTROENTEROL, V5, P789, DOI 10.1016/S2468-1253(20)30237-5eng
hcfmusp.relation.reference[Anonymous], 2017, GLOB HEP REP 2017eng
hcfmusp.relation.referenceAquino Estela M. L., 2020, Ciênc. saúde coletiva, V25, P2423eng
hcfmusp.relation.referenceAwucha NE, 2020, AM J TROP MED HYG, V103, P1630, DOI 10.4269/ajtmh.20-0838eng
hcfmusp.relation.referenceCadogan CA, 2021, RES SOC ADMIN PHARM, V17, P2032, DOI 10.1016/j.sapharm.2020.03.015eng
hcfmusp.relation.referenceCoroiu A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239795eng
hcfmusp.relation.referencede Fraga RS, 2020, J GASTROENTEROL, V55, P496, DOI 10.1007/s00535-020-01680-0eng
hcfmusp.relation.referenceFord N, 2018, HEPATOL COMMUN, V2, P1160, DOI 10.1002/hep4.1247eng
hcfmusp.relation.referenceHa NB, 2016, J CLIN GASTROENTEROL, V50, P169, DOI 10.1097/MCG.0000000000000345eng
hcfmusp.relation.referenceKretchy IA, 2021, RES SOC ADMIN PHARM, V17, P2023, DOI 10.1016/j.sapharm.2020.04.007eng
hcfmusp.relation.referenceLevorato Cleice Daiana, 2014, Ciênc. saúde coletiva, V19, P1263, DOI 10.1590/1413-81232014194.01242013eng
hcfmusp.relation.referenceLieveld FI, 2013, ANN HEPATOL, V12, P380, DOI 10.1016/S1665-2681(19)31000-2eng
hcfmusp.relation.referenceZheng SQ, 2021, RES SOC ADMIN PHARM, V17, P1819, DOI 10.1016/j.sapharm.2020.03.012eng
hcfmusp.relation.referenceCasos confirmados notificados no sistema de informação de agravos de notificação - São Pauloeng
hcfmusp.relation.reference2016, Protocolo Clinico e Diretrizes Terapeutica para Hepatitie C e Coinfeccoes. Brasilia 2011eng
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublicationbeff0087-bd2a-4490-a5d0-15176e2ead34
relation.isAuthorOfPublication69285424-3163-4292-80ee-a26fb84289c9
relation.isAuthorOfPublication6753819a-cac8-40f0-a177-4d971d93d80f
relation.isAuthorOfPublicationf49d7b43-1452-4a2a-b4d0-cd8ee887852f
relation.isAuthorOfPublication.latestForDiscoverybeff0087-bd2a-4490-a5d0-15176e2ead34
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
art_BERTOLLI_Access_to_antiviral_therapy_for_chronic_hepatitis_B_2022.PDF
Tamanho:
213.22 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MGT
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/07
Artigos e Materiais de Revistas Científicas - ODS/03